| Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody–associated small-vessel vasculitis SL Hogan, RJ Falk, H Chin, J Cai, CE Jennette, JC Jennette, ... Annals of internal medicine 143 (9), 621-631, 2005 | 565 | 2005 |
| Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis RJ Falk, WL Gross, L Guillevin, G Hoffman, DRW Jayne, JC Jennette, ... Annals of the Rheumatic Diseases 70 (4), 704-704, 2011 | 531 | 2011 |
| Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. SL Hogan, PH Nachman, AS Wilkman, JC Jennette, RJ Falk Journal of the American Society of Nephrology 7 (1), 23-32, 1996 | 448 | 1996 |
| Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in … S Lionaki, ER Blyth, SL Hogan, Y Hu, BA Senior, CE Jennette, ... Arthritis & Rheumatism 64 (10), 3452-3462, 2012 | 429 | 2012 |
| Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. PH Nachman, SL Hogan, JC Jennette, RJ Falk Journal of the American Society of Nephrology 7 (1), 33-39, 1996 | 410 | 1996 |
| Mycophenolate mofetil therapy in lupus nephritis: clinical observations MA Dooley, FG Cosio, PH Nachman, ME Falkenhain, SL Hogan, RJ Falk, ... Journal of the American Society of Nephrology 10 (4), 833-839, 1999 | 364 | 1999 |
| Rituximab therapy in idiopathic membranous nephropathy: a 2-year study FC Fervenza, RS Abraham, SB Erickson, MV Irazabal, A Eirin, U Specks, ... Clinical journal of the American Society of Nephrology 5 (12), 2188-2198, 2010 | 338 | 2010 |
| Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations DC Cattran, E Alexopoulos, P Heering, PF Hoyer, A Johnston, A Meyrier, ... Kidney international 72 (12), 1429-1447, 2007 | 334 | 2007 |
| ANCA glomerulonephritis and vasculitis JC Jennette, PH Nachman Clinical Journal of the American Society of Nephrology 12 (10), 1680-1691, 2017 | 333 | 2017 |
| Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody–associated small‐vessel vasculitis: comparison of two independent cohorts C Pagnoux, SL Hogan, H Chin, JC Jennette, RJ Falk, L Guillevin, ... Arthritis & Rheumatism 58 (9), 2908-2918, 2008 | 320 | 2008 |
| Kidney disease: improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis DC Cattran, J Feehally, HT Cook, ZH Liu, FC Fervenza, SA Mezzano, ... Kidney International Supplements 2 (2), 139-274, 2012 | 316 | 2012 |
| Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach CA Gadegbeku, DS Gipson, LB Holzman, AO Ojo, PXK Song, L Barisoni, ... Kidney international 83 (4), 749-756, 2013 | 298 | 2013 |
| Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference J Floege, SJ Barbour, DC Cattran, JJ Hogan, PH Nachman, SCW Tang, ... Kidney international 95 (2), 268-280, 2019 | 274 | 2019 |
| Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis AJ Roth, JD Ooi, JJ Hess, MM Van Timmeren, EA Berg, CE Poulton, ... The Journal of clinical investigation 123 (4), 1773-1783, 2013 | 274 | 2013 |
| Venous thromboembolism in patients with membranous nephropathy S Lionaki, VK Derebail, SL Hogan, S Barbour, T Lee, M Hladunewich, ... Clinical Journal of the American Society of Nephrology 7 (1), 43-51, 2012 | 232 | 2012 |
| Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis SJ Barbour, A Greenwald, O Djurdjev, A Levin, MA Hladunewich, ... Kidney international 81 (2), 190-195, 2012 | 213 | 2012 |
| Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis PH Nachman, M Segelmark, K Westman, SL Hogan, KK Satterly, ... Kidney international 56 (4), 1544-1550, 1999 | 199 | 1999 |
| Long-term glycemic control measurements in diabetic patients receiving hemodialysis MS Joy, WT Cefalu, SL Hogan, PH Nachman American journal of kidney diseases 39 (2), 297-307, 2002 | 196 | 2002 |
| Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis SL Hogan, KK Satterly, MA Dooley, PH Nachman, JC Jennette, RJ Falk Journal of the American Society of Nephrology 12 (1), 134-142, 2001 | 187 | 2001 |
| Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference BH Rovin, DJ Caster, DC Cattran, KL Gibson, JJ Hogan, MJ Moeller, ... Kidney international 95 (2), 281-295, 2019 | 184 | 2019 |
